Opinion: WTO waiver is important, but so is fixing SA’s outdated patent laws

The World Trade Organization TRIPS council is expected to vote on South Africa and India’s proposed patent waiver on 10 or 11 March which could, if granted, help countries to scale up production of COVID-19 vaccines. But, while the waiver is important, argues Julia Chaskalson, it is also urgent that South Africa should amend its outdated domestic patent laws.

Read More

COVID-19: Are foreign nationals being left behind?

Some foreign nationals in South Africa, their community leaders, human rights lawyers and activists are concerned that their health needs are falling through the cracks. This was compounded during lockdown with some foreign nationals claiming they were refused healthcare and others now concerned they will be excluded from the vaccine rollout. Luvuyo Mehlwana reports.

Read More

What SA’s COVID-19 experience tells us about NHI

For all the suffering and death the COVID-19 pandemic has caused over the last 12 months, it has arguably also provided a unique opportunity to test some of the mechanisms behind South Africa’s proposed National Health Insurance (NHI) system. The centralised procurement of vaccines and the contracting of doctors, for example, are probably not dissimilar from the arrangements we might see under NHI. Kathryn Cleary asks three leading health experts what lessons, for NHI, we should learn from the COVID-19 response.

Read More

Analysis: How do you price a life-saving vaccine during a pandemic?

In late January, Dr Anban Pillay, Deputy Director-General in South Africa’s National Department of Health, revealed that South Africa would pay more than double the price paid by the European Union (EU) for AstraZeneca’s COVID-19 vaccine. This set off a flurry of questions on how vaccine prices are set and why, in many cases, the prices themselves are not known to the public. Catherine Tomlinson takes a closer look at the issues involved.

Read More

Opinion: Health budget slashed despite vaccine commitments

The national budget tabled this week shows that planned spending on public health is reduced by a massive R50.3 billion over the next three years. We cannot accept a vaccine versus health system trade-off. Government must both expedite the procurement of vaccines and ensure that provinces have the staff and other capabilities to rapidly roll them out and to maintain and improve the quality of healthcare services, argue writers from SECTION27.

Read More

Rolling out the vaccine: Provincial plans compared

Provinces manage the day-to-day running of the public healthcare system in South Africa and provinces will be responsible for the massive logistical effort of getting COVID-19 vaccines from fridges and depots into people’s arms. Elri Voigt has been keeping track of the nine provinces’ plans.

Read More

Opinion: Pivot to J&J vaccine makes sense in light of new findings

Government deserves criticism for various aspects of its COVID-19 response, but some social media criticism following Sunday’s announcement that the Oxford University/AstraZeneca vaccine has little or no efficacy in preventing mild-to-moderate disease caused by the 501Y.V2 variant has been unfair, writes Marcus Low.

Read More